B.F. Boyce

FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE

B.F. Boyce, I. Fogelman, Stuart H. Ralston et al. · The Lancet · 1984 · 198 citations

Medicine, Radiology, Bone Metabolism +7

HYPERCALCAEMIC OSTEOMALACIA DUE TO ALUMINIUM TOXICITY

B.F. Boyce, H. Y. Elder, Heidi Elliot et al. · The Lancet · 1982 · 167 citations

Medicine, Toxicology, Bone Metabolism +9

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis

David Roblin, Gil Yosipovitch, B.F. Boyce et al. · Acta Dermato Venereologica · 2015 · 117 citations · Full text

Medicine, Dermatology, Pharmacology +10

The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research

DG Hicks, B.F. Boyce · Biotechnic & Histochemistry · 2011 · 53 citations

Medicine, Oncology, Pathology +16

Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia.

B.F. Boyce, James Byars, S. McWilliams et al. · Journal of Clinical Pathology · 1992 · 46 citations · Full text

Medicine, Oral Pathology, Bone Metabolism +12